Regenxbio (RGNX) hit by FDA CRL for RGX-121; valuation discount, cash runway to 2027, risks vs RGX-202 upside. Click here to ...

Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth quarter-over-quarter2025 year-end cash and cash equivalents of $226.

Each year, families leave money on the table by moving too quickly to file their taxes. Experts explained the tax breaks middle-class families may be missing.

The report said Denver’s restaurant industry is “contracting, as restaurants are facing rising costs across every major expense.

Grasp your bar with an overhand grip, hands wider than shoulder width-apart. Hang from the bar. Pull your shoulders blades ...

View post: Macy's is selling a $60 3-piece quilt set for just $13 during a limited-time Last Act deal Loyalty programs boost spending; members spend more annually than nonmembers. A well-known ...

Henry Ford famously noted, “Whether you think you can do it or not, you are usually right.” His point was that beliefs, especially about our talents, performance, and even luck, can be self-fulfilling ...

Plaintiff class action lawyers believe that they have found a new type of employee benefit program to go after for potential fiduciary breach violations – voluntary benefits. On December 23, 2025, ...

The Milwaukee Department of Emergency Communications announced the launch of "Project Forward 911," an artificial intelligence-assisted program. The program uses AI to help with quality assurance and ...

Facing the loss of exclusivity on key products, Pfizer has pulled forward its lead obesity asset into Phase III and targeted a 2028 launch. CEO Albert Bourla explained the pharma’s strategy at J.P.